Brief: Qualigen Therapeutics To Acquire Majority Stake In Diagnostics Technology Company Nanosynex

Aixcrypto Holdings

03/05/2022 14:32

May 3 (Reuters) - Qualigen Therapeutics Inc  QLGN.O :
    * QUALIGEN THERAPEUTICS TO ACQUIRE MAJORITY STAKE IN
DIAGNOSTICS
TECHNOLOGY COMPANY NANOSYNEX
    * QUALIGEN - DEAL FOR CONTROLLING INTEREST IN NANOSYNEX TO
BE
PRIMARILY COMPRISED OF STOCK-FOR-STOCK ACQUISITION WITH 
NANOSYNEX CONTROLLING SHAREHOLDER
    * QUALIGEN THERAPEUTICS INC - PURCHASE OF CONTROLLING
INTEREST IN
NANOSYNEX WILL BE COMPRISED OF AN INITIAL $600,000 CASH
INVESTMENT
    * QUALIGEN - EXPECTS TO CONSOLIDATE FINANCIAL RESULTS OF
NANOSYNEX, & PROVIDE FUTURE MILESTONE-BASED FUNDING LEADING TO
COMMERCIALIZATION OF TECHNOLOGY

Source text for Eikon:  ID:nGNX7bRdrX 
Further company coverage:  QLGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))